PBYIPuma Biotechnology, Inc.
7.040USD-1.95%Mkt Cap: 358.08M USDP/E: 14.66Last update: 2026-06-01

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of n…

Indicators:|

Key Statistics

Company
Market Cap358.08M USD
Enterprise Value279.10M USD
Revenue (TTM)227.18M USD
Gross Profit170.21M USD
Net Income (TTM)31.11M USD
Revenue/Share4.514 USD
Last Price7.040 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees179
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)14.66
P/E (Forward)20.49
PEG
EV/EBITDA7.08
EV/Revenue1.23
P/S1.61
P/B2.84
EPS (TTM)0.48
EPS (Forward)0.35
52W Range
3.03082% of range7.900
52W High7.900 USD
52W Low3.030 USD
Profitability
Gross Margin74.53%
Oper. Margin-8.54%
EBITDA Margin17.35%
Profit Margin13.62%
ROE23.87%
ROA14.38%
Growth
Revenue Growth-2.60%
Earnings Growth
Cash Flow & Leverage
Operating CF41.80M USD
CapEx (TTM)71.00K USD
FCF Margin19.41%
FCF Yield12.31%
Net Debt-85.59M USD
Net Debt/EBITDA-2.17
Balance Sheet
Debt/Equity0.22
Current Ratio2.38
Quick Ratio2.14
Book Value/Sh2.524 USD
Cash/Share1.995 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)5.000 USD
Target Range5.000 USD5.000 USD
# Analysts1
Ownership
Shares Out.50.90M
Float39.09M
Insiders15.38%
Institutions77.52%
Short Interest
Short Ratio14.5d
Short % Float9.67%
Short % Out.8.24%
Shares Short4.19M
Short (prev mo.)4.16M
Technical
SMA 507.072 (-0.4%)
SMA 2005.982 (+17.7%)
Beta1.23
S&P 52W Chg27.70%
Avg Vol (30d)245.17K
Avg Vol (10d)198.09K
Technical Indicators
RSI (14)50.6
MACD-0.0069
MACD Signal-0.0111
MACD Hist.+0.0042
BB Upper7.613 USD
BB Middle7.188 USD
BB Lower6.763 USD
BB Width11.83%
ATR (14)0.2852 USD
Vol Ratio (20d)0.46x